Further investigation into the specific amino acids responsible for the binding of MTBP to Tip48/Tip49 as well as crystallization of this structure may allow for development of potential therapeutics to target MTBP in cancer, as has been accomplished with other MYC cofactors [142,143,144,145,146,147,148,149,150]. The gene discussed is MYC; the disease is cancer.